From the Editor-in-Chief
More basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
How can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
Putting the Immune System in Overdrive | Weighty Matters | A Blood Test for Cancer | Melanoma Risk Increased in Some Lymphoma Survivors | Aspirin Recommended to Reduce Colorectal Cancer Risk | Fine-Tuning Treatments for Triple-Negative Breast Cancer | Don't Get Burned
Your Cancer Guide
Complementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
Caregiving With Confidence
Follow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
Pain is no gain for patients during or after cancer treatment.
by Sue Rochman
A metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
What's The Beef? | Less Stress
Cancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
When a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial.
Give patients and their families a break from cancer.
by Maria Wolf
Colleen Bokor, Dana Stewart, Brittany Avin.
My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.
by Allison Rosen
Researchers are investigating why certain patients have an exceptional response to a particular drug.
by Bradley Jones
Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.
by Kate Yandell
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
A session highlighted immunotherapy combinations and a liquid biopsy-based strategy for predicting progression-free survival.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
While melanoma is rarer than other forms of skin cancer, it is more aggressive and more likely to spread to other organs.
Handle With Care
donate to the AACR